131 related articles for article (PubMed ID: 17062883)
1. Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves' ophthalmopathy patients.
Konuk EB; Konuk O; Misirlioglu M; Menevse A; Unal M
Eur J Endocrinol; 2006 Nov; 155(5):681-5. PubMed ID: 17062883
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy.
Konuk O; Hondur A; Akyurek N; Unal M
Ocul Immunol Inflamm; 2007; 15(2):105-11. PubMed ID: 17558835
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
4. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
5. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
[TBL] [Abstract][Full Text] [Related]
6. Detection of thyroid peroxidase mRNA and protein in orbital tissue.
Lai OF; Zaiden N; Goh SS; Mohamed NE; Seah LL; Fong KS; Estienne V; Carayon P; Ho SC; Khoo DH
Eur J Endocrinol; 2006 Aug; 155(2):213-8. PubMed ID: 16868133
[TBL] [Abstract][Full Text] [Related]
7. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of connective tissue growth factor (CTGF) in Graves' ophthalmopathy.
Huang YM; Chang PC; Wu SB; Kau HC; Tsai CC; Liu CJ; Wei YH
Br J Ophthalmol; 2017 May; 101(5):676-680. PubMed ID: 27543288
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
Tsai CC; Wu SB; Chang PC; Wei YH
PLoS One; 2015; 10(11):e0143514. PubMed ID: 26599235
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
[TBL] [Abstract][Full Text] [Related]
12. Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon.
Potgieser PW; Wiersinga WM; Regensburg NI; Mourits MP
Eur J Endocrinol; 2015 Aug; 173(2):149-53. PubMed ID: 26142100
[TBL] [Abstract][Full Text] [Related]
13. Thyroid volume and severity of Graves' orbitopathy.
Profilo MA; Sisti E; Marcocci C; Vitti P; Pinchera A; Nardi M; Rocchi R; Latrofa F; Menconi F; Altea MA; Leo M; Rago T; Marinò M
Thyroid; 2013 Jan; 23(1):97-102. PubMed ID: 23088654
[TBL] [Abstract][Full Text] [Related]
14. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
[TBL] [Abstract][Full Text] [Related]
15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue.
Lisi S; Marinò M; Pinchera A; Mazzi B; Di Cosmo C; Sellari-Franceschini S; Chiovato L
Thyroid; 2002 May; 12(5):351-60. PubMed ID: 12097194
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy.
Yoon JS; Chae MK; Lee SY; Lee EJ
Br J Ophthalmol; 2012 Aug; 96(8):1117-21. PubMed ID: 22661653
[TBL] [Abstract][Full Text] [Related]
18. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
Kumar S; Coenen MJ; Scherer PE; Bahn RS
J Clin Endocrinol Metab; 2004 Feb; 89(2):930-5. PubMed ID: 14764816
[TBL] [Abstract][Full Text] [Related]
19. Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathy.
Pawlowski P; Wawrusiewicz-Kurylonek N; Eckstein A; Reszec J; Luczynski W; Johnson K; Kretowski A; Bakunowicz-Lazarczyk A; Gorska M; Szamatowicz J; Chyczewski L; Mysliwiec J
Mediators Inflamm; 2015; 2015():340934. PubMed ID: 25653477
[TBL] [Abstract][Full Text] [Related]
20. [Endoscopic trans-ethmoid medial orbital wall decompression combined with intraconal fat decompression for Graves' ophthalmopathy].
Wu WC; Yu B; Wang ML; Huang L; Tu YH; Chen B; Qu J; Wang QM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):807-13. PubMed ID: 22321417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
